According to Zhitong Finance App News, Ruili Medical & Aesthetic (02135) announced that since all conditions contained in the underwriting agreement have been met, and the underwriter did not terminate the underwriting agreement before the final termination time limit, the stock offering was becoming unconditional at 4:00 p.m. on April 18, 2024 (Thursday). The net proceeds from the stock offering were approximately HK$19.2 million.

In total, it has received 8 provisional quota notices and valid applications under additional application forms, involving a total of approximately 183 million shares offered, which is equivalent to about 131.7% of the total number of shares offered for subscription under the offering.

According to the above results, the shares offered were oversubscribed by about 44.1238 million shares, which is equivalent to about 31.7% of the total number of shares that can be subscribed under the share offering of approximately 139 million shares.

As the shares offered were oversubscribed (after taking into account valid applications for additional shares), the underwriter's liability under the underwriting agreement with respect to the underwriting of the shares has been lifted.